Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
phd_neuroscience.png
 
 
 
Hauptnavigation
  • Home
  • General Informations
  • Research Laboratories
  • PhD Students
  • Lectures & Courses
 
PhD Neuroscience / PhD Students / Agnieszka Buda
 
Subnavigation
  • Cinzia Barresi
  • Elisa Briem
  • Agnieszka Buda
  • Genova Carrero Rojas
  • Greta Crudeli
  • Laura Sabina Cuenca Rico
  • Julia Elis
  • Filip Dikic
  • Dominik Dotzauer
  • Rozalina Galimullina
  • Yaakov Gershtein
  • Sarah Glatter
  • Vanessa Goeschl
  • Maximilian Haertinger
  • Sergey Isaev
  • Zlata Kiseleva
  • Laura Klinger
  • Sebastian Klug
  • Florian Jaklin
  • Anselm Jorda
  • Georg Ladurner
  • Gregor Laengle
  • Udo Maierhofer
  • Ksenija Martinovic
  • Dimitrios Mariatos Metaxas
  • Flavia Millesi
  • Salome Niethammer
  • Bettina Pfeffer
  • Olga Politikou
  • Irina Poverennaya
  • Laurin Rauter
  • Lorenz Semmler
  • Ana Sofia Alberto e Silva
  • Sarah Stadlmayr
  • Anja Steinmaurer
  • Paul Supper
  • Amina Telalovic
  • Helena Untersteiner
  • Didem Uen
  • Andrea Villoria-Gonzalez
  • Florian Vogel
  • Johannes Zeilinger
  • Michaela Zrelski
  • Maja Zupancic
  • Ben-Orli Nathanson
  • Alumni


Inhaltsbereich


MSc Agnieszka Buda

Department(s): Department of Pathobiology of the Nervous System (Center for Brain Research)
Position: PHD Student
Location: Spitalgasse 4
Telephone: 40160-34091
E-Mail:


Principle Investigator(s):

  • Berger, Johannes


Abstract:

X-linked adrenoleukodystrophy (X-ALD) is a progressive neurometabolic disorder caused by an ABCD1 mutation, leading to accumulation of very long-chain fatty acids in tissues and plasma. Clinically, X-ALD presents as a spectrum of symptoms with the most severe form - cerebral X-ALD, characterised by rapid inflammatory demyelination in cerebral white matter.
The aim of my project is to study cholesterol metabolism in X-ALD derived cells and its potential involvement in the disease manifestation and progression. We hope to establish the intracellular consequences of altered cholesterol metabolism in X-ALD, with the special regard of the impact of the immune response. 


Techniques:

X-ALD patients and control derived primary cell culture: monocyte isolation from the blood and further in vitro differentiation into macrophages; primary skin fibroblasts culture
-    Gene expression analysis: RT-qPCR, Western Blot
-    Microarray or RNA-seq data analysis with the use of the Qlucore Omics Explorer software
-    Fluorescent microscopy
-    FACS analysis (Guava® easyCyte™ Flow Cytometer)
-    Lipid extraction and cholesterol measurement using commercially available kits
-    Lipid staining (Oil Red O, Filipin III, TopFluor Cholesterol) 


Selected Publications:

  1. Zierfuss B, Weinhofer I, Buda A, Popitsch N, Hess L, Moos V, Hametner S, Kemp S, Köhler W, Forss‐Petter S, Seiser C, Berger J (2020) Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS‐275 Ann Clin Transl Neurol,

Show all publications

 
Drucken
 
 
© MedUni Wien  | 
 Publishing information | Terms of use | Accessibility | Contact